4.3 Risk-related factors: exposure characteristics, co-occurring symptoms, and baseline susceptibility Within the current evidence base, the occurrence and phenotype of GLP-1RA-associated changes in eating experience can be interpreted as being shaped by exposure characteristics, co-occurring symptoms, and individual susceptibility
Sheer and colleagues reviewed electronic health record data from 26,408 adults treated in the OneFlorida+ network from 2014 to 2024, covering 14 healthcare organizations across Florida, Georgia, and Alabama
Other gastrointestinal effects to monitor include vomiting, diarrhea, abdominal pain, and constipation
Is Alcohol Consumption Safe While Taking GLP-1 Medication
Ozempic is the latest big deal in the weight loss world
However, severe, persistent abdominal painespecially if accompanied by vomiting, inability to eat or drink, or fevershould be evaluated by a healthcare provider to rule out pancreatitis or other serious conditions
